Stimulation of lipolysis and the induction of resistance to insulin's actio
ns on glucose metabolism are well-recognized effects of growth hormone (GH)
. To evaluate whether these two features are causally linked, we studied th
e impact of pharmacologically induced antilipolysis in seven GH-deficient p
atients (mean [+/- SE] age 37 +/- 4 years). Each subject was studied under
four different conditions: during continuation of GH replacement alone (A),
after discontinuation of GH replacement for 2 days (B), after GH replaceme
nt and shortterm coadministration of acipimox (250 mg, p.o., b.i.d., for 2
days) (C), and after administration of acipimox alone (D). At the end of ea
ch study, total and regional substrate metabolisms were assessed in the bas
al state and after a 3-h hyperinsulinemic/euglycemic clamp. Serum levels of
free fatty acids (FFAs) were elevated with GH alone (A) and suppressed wit
h acipimox (C and D). Basal rates of lipid oxidation were highest with GH a
lone (A), and suppressed by 50% with acipimox (B versus D, P < 0.01; A vers
us C, P < 0.05). Basal glucose oxidation rates were lowest with GH alone (A
) and highest with acipimox (C and D) (P = 0.01). Insulin-stimulated rates
of total glucose turnover were significantly lower with GH alone as compare
d with all other conditions (P = 0.004). Insulin sensitivity as assessed by
the M value (rate of glucose infusion) was reduced with GH alone as compar
ed with all other conditions M value in mg . kg(-1) . min(-1): GH alone [A]
, 2.55 +/- 0.64; discontinuation of GH [B], 4.01 +/- 0.70; GH plus acipimox
[C], 3.96 +/- 1.34; acipimox alone [D], 4.96 +/- 0.91; P < 0.01). During p
harmacological antilipolysis, GH did not significantly influence insulin se
nsitivity (C versus D; P = 0.19). From our results, we reached the followin
g conclusions: 1) Our data strongly suggest that the insulin antagonistic a
ctions of GH on glucose metabolism are causally linked to the concomitant a
ctivation of lipolysis. 2) In addition, GH may induce residual insulin resi
stance through non-FFA-dependent mechanisms. 3) The cellular and molecular
mechanisms subserving the insulin antagonistic effects of GH remain to be e
lucidated.